Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHERISSE M PERU

Allopathic & Osteopathic Physicians Family Medicine

NPI
1417598020
CMS profile
7217434
Location
LANSING, MI

General Payments · PY2020–2024

$1,414.18

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$783.54

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $740.42 36
Education $43.12 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $15.34 1
PY2021 $71.42 4
PY2022 $88.70 4
PY2023 $455.18 18
PY2024 $783.54 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $20.64 01/16/2024 Food and Beverage Undisputed 01/23/2026 1125831177 CMS
Amgen Inc. $16.07 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116012680 CMS
Amgen Inc. $14.01 09/23/2024 Food and Beverage Undisputed 01/23/2026 1117654094 CMS
Ardelyx, Inc. $15.70 11/07/2024 Food and Beverage Undisputed 01/23/2026 1146741249 CMS
AstraZeneca Pharmaceuticals LP $23.39 02/06/2024 Food and Beverage Undisputed 01/23/2026 1123302488 CMS
AstraZeneca Pharmaceuticals LP $23.20 08/13/2024 Food and Beverage Undisputed 01/23/2026 1123311004 CMS
AstraZeneca Pharmaceuticals LP $19.80 09/10/2024 Food and Beverage Undisputed 01/23/2026 1123309014 CMS
AstraZeneca Pharmaceuticals LP $24.29 10/22/2024 Food and Beverage Undisputed 01/23/2026 1123311172 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.14 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086280642 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.21 03/11/2024 Food and Beverage Undisputed 01/23/2026 1086272294 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.49 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086325108 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.50 12/18/2024 Food and Beverage Undisputed 01/23/2026 1086328527 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.81 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118001339 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.17 10/02/2024 Food and Beverage Undisputed 01/23/2026 1118001337 CMS
CALLIDITAS THERAPEUTICS US INC. $22.16 03/05/2024 Food and Beverage Undisputed 01/23/2026 1141510753 CMS
CALLIDITAS THERAPEUTICS US INC. $20.52 05/07/2024 Food and Beverage Undisputed 01/23/2026 1141514595 CMS
CALLIDITAS THERAPEUTICS US INC. $20.92 07/15/2024 Food and Beverage Undisputed 01/23/2026 1141518473 CMS
CALLIDITAS THERAPEUTICS US INC. $19.13 08/07/2024 Food and Beverage Undisputed 01/23/2026 1141519991 CMS
Cycle Pharmaceuticals Inc $24.30 10/03/2024 Food and Beverage Undisputed 01/23/2026 1154920614 CMS
Fresenius USA Marketing, Inc. $19.82 01/18/2024 Food and Beverage Undisputed 01/23/2026 1154206608 CMS
Fresenius USA Marketing, Inc. $18.74 02/20/2024 Food and Beverage Undisputed 01/23/2026 1154206606 CMS
Fresenius USA Marketing, Inc. $22.09 08/06/2024 Food and Beverage Undisputed 01/23/2026 1154206610 CMS
GENZYME CORPORATION $17.42 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139572392 CMS
Lilly USA, LLC $16.25 11/20/2024 Food and Beverage Undisputed 01/23/2026 1135624101 CMS
Mallinckrodt Hospital Products Inc. $27.03 02/29/2024 Food and Beverage Undisputed 01/23/2026 1145182309 CMS
Novartis Pharmaceuticals Corporation $15.02 10/31/2024 Food and Beverage Undisputed 01/23/2026 1087344747 CMS
Novo Nordisk Inc $19.14 07/23/2024 Food and Beverage Undisputed 01/23/2026 1108567599 CMS
Novo Nordisk Inc $25.55 09/11/2024 Food and Beverage Undisputed 01/23/2026 1108566943 CMS
Novo Nordisk Inc $16.53 11/13/2024 Food and Beverage Undisputed 01/23/2026 1108572830 CMS
NXSTAGE MEDICAL, INC. $20.09 05/22/2024 Food and Beverage Undisputed 01/23/2026 1154282661 CMS
OPKO Pharmaceuticals, LLC $23.06 08/08/2024 Education Undisputed 01/23/2026 1112853870 CMS
OPKO Pharmaceuticals, LLC $20.06 10/24/2024 Education Undisputed 01/23/2026 1112853872 CMS
Otsuka America Pharmaceutical, Inc. $24.92 06/25/2024 Food and Beverage Undisputed 01/23/2026 1119161899 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $22.65 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118843271 CMS
Travere Therapeutics, Inc. $31.41 05/22/2024 Food and Beverage Undisputed 01/23/2026 1149948679 CMS
Travere Therapeutics, Inc. $38.81 07/19/2024 Food and Beverage Undisputed 01/23/2026 1149948683 CMS
Xeris Pharmaceuticals, Inc. $16.21 01/23/2024 Food and Beverage Undisputed 01/23/2026 1144622838 CMS
Xeris Pharmaceuticals, Inc. $21.29 04/11/2024 Food and Beverage Undisputed 01/23/2026 1144622840 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.